Company Zhejiang Huahai Pharmaceutical Co., Ltd.

Equities

600521

CNE000001DL5

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
15.84 CNY +0.96% Intraday chart for Zhejiang Huahai Pharmaceutical Co., Ltd. +4.49% +7.98%

Business Summary

ZHEJIANGHUAHAIPHARMACEUTICALCO., LTD is a China-based company, principally engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine hydrochloride tablets, risperidone tablets, fosinopril sodium tablets, as well as irbesartan and hydrochlorothinzide tablets, among others. The Company also provides related technical support services. The Company distributes its products in domestic and overseas markets.

Number of employees: 7,682

Sales per Business

CNY in Million2021Weight2022Weight Delta
Finished Drugs
57.1 %
3,646 54.9 % 4,721 57.1 % +29.49%
Raw Materials & Intermediates
39.8 %
2,771 41.7 % 3,288 39.8 % +18.67%
Import and Export Trade
1.6 %
139 2.1 % 136 1.6 % -2.09%
Other Business
1.0 %
41 0.6 % 83 1.0 % +101.63%
Technical Services
0.4 %
46 0.7 % 34 0.4 % -27.24%
Other
0.1 %
1 0.0 % 4 0.1 % +386.52%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
51.6 %
3,295 49.9 % 4,224 51.6 % +28.20%
Foreign
48.4 %
3,307 50.1 % 3,959 48.4 % +19.69%

Managers

Managers TitleAgeSince
Director of Finance/CFO 48 08-05-31
President 62 07-03-31
Director/Board Member 61 17-04-20
Director/Board Member 59 -
Investor Relations Contact - -
Corporate Officer/Principal 66 04-04-09

Members of the board

Members of the board TitleAgeSince
President 62 07-03-31
Director/Board Member 59 -
Chairman 75 10-04-14
Director/Board Member 62 19-05-20
Director/Board Member 63 13-03-25
Director/Board Member 52 22-05-16
Director/Board Member 52 07-04-02
Chairman 63 19-05-20
Director/Board Member 61 17-04-20
Director/Board Member 57 22-04-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,515,818,000 855,456,679 ( 56.44 %) 33,310,855 ( 2.198 %) 56.44 %

Shareholders

NameEquities%Valuation
365,697,935 25.14 % 653 M ¥
224,418,890 15.43 % 401 M ¥
Guotai Asset Management Co., Ltd.
1.248 %
18,153,652 1.248 % 32 M ¥
China Merchants Fund Management Co., Ltd.
1.021 %
14,852,043 1.021 % 27 M ¥
Taizhou State Owned Assets Supr & Admin Commission
0.8568 %
12,462,871 0.8568 % 22 M ¥
Essence Fund Co., Ltd.
0.8324 %
12,108,917 0.8324 % 22 M ¥
Zhong Ou Asset Management Co., Ltd
0.8161 %
11,871,069 0.8161 % 21 M ¥
10,656,753 0.7326 % 19 M ¥
City of Linhai
0.6287 %
9,145,526 0.6287 % 16 M ¥
Rongtong Fund Management Co., Ltd.
0.6214 %
9,039,520 0.6214 % 16 M ¥
NameEquities%Valuation
Hong Li
0.7657 %
200,000 0.7657 % 356 972 ¥
180,000 0.6892 % 321 275 ¥
Si Jia Guo
0.6126 %
160,000 0.6126 % 285 578 ¥
Mei Zhang
0.5360 %
140,000 0.5360 % 249 880 ¥
140,000 0.5360 % 249 880 ¥
Qimao Chen
0.5360 %
140,000 0.5360 % 249 880 ¥
122,500 0.4690 % 218 645 ¥
Yan Su
0.1531 %
40,000 0.1531 % 71 394 ¥
Bo Xu
0.0919 %
24,000 0.0919 % 42 837 ¥

Holdings

NameEquities%Valuation
10,656,753 0.73% 19,020,812 $
14,697,053 4.26% 11,529,985 $

Company contact information

Zhejiang Huahai Pharmaceutical Co., Ltd.

Xunqiao Town Economic Development Zone

317024, Linhai

+86 576 8501 0288

http://www.huahaipharm.com
address Zhejiang Huahai Pharmaceutical Co., Ltd.(600521)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
15.69 CNY
Average target price
16.37 CNY
Spread / Average Target
+4.31%
Consensus
  1. Stock Market
  2. Equities
  3. 600521 Stock
  4. Company Zhejiang Huahai Pharmaceutical Co., Ltd.